首页|甘草泻心汤加减联合美沙拉嗪对溃疡性结肠炎肠道功能屏障及色氨酸代谢的影响分析

甘草泻心汤加减联合美沙拉嗪对溃疡性结肠炎肠道功能屏障及色氨酸代谢的影响分析

扫码查看
目的 探讨甘草泻心汤加减联合美沙拉嗪对溃疡性结肠炎(Ulcerative colitis,UC)患者肠道功能屏障及色氨酸代谢的影响。方法 选择医院于2019年4月—2021年4月就诊的UC患者142例,依据随机数字表法随机分为观察组(71例)与对照组(71例)。对照组患者给予美沙拉嗪治疗,观察组在对照组基础上结合甘草泻心汤加减治疗。两组治疗疗程12周。比较两组治疗12周临床疗效,治疗前与治疗12周肠道黏膜病变严重程度(改良Mayo评分和Geboes指数)、肠道屏障功能[内毒素、二胺氧化酶(Diamine oxidase,DAO)和D-乳酸]、色氨酸代谢[犬尿氨酸(Kynurenine,Kyn)、犬尿喹啉酸(Kynurenic acid,KynA)和喹啉酸(QuinA)]及药物不良反应。结果 观察组UC患者治疗总有效率(91。55%,65/71)高于对照组(74。65%,53/71)(P<0。05)。两组治疗12周UC患者改良Mayo评分和Geboes指数较治疗前降低(P<0。05);观察组治疗12周UC患者改良Mayo评分和Geboes指数低于对照组(P<0。05)。两组治疗12周UC患者内毒素、DAO和D-乳酸水平较治疗前降低(P<0。05);观察组治疗12周UC患者内毒素、DAO和D-乳酸水平低于对照组(P<0。05)。两组治疗12周UC患者QuinA/Kyn较治疗前降低,而KynA/QuinA和Kyn A/Kyn较治疗前升高(P<0。05);观察组治疗12周UC患者QuinA/Kyn低于对照组,而KynA/QuinA和KynA/Kyn高于对照组(P<0。05)。两组治疗12周UC患者IBDQ评分较治疗前增加(P<0。05);观察组治疗12周UC患者IBDQ评分高于对照组(P<0。05)。两组患者用药期间均未发生明显不良反应。结论 甘草泻心汤加减联合美沙拉嗪对UC患者疗效良好,可减轻患者肠道黏膜病变严重程度,改善患者肠道屏障功能和色氨酸代谢。
Effect of Modified Gancao Xiexin Decoction(甘草泻心汤加减)Combined with Mesalazine on Intestinal Functional Barrier and Tryptophan Metabolism in Patients with Ulcerative Colitis
Objective To investigate the effect of Modified Gancao Xiexin Decoction(甘草泻心汤加减)combined with me-salazine on the intestinal function barrier and tryptophan metabolism in patients with ulcerative colitis(UC).Methods A total of 142 UC patients in the hospital from April 2019 to April 2021 were selected and randomly divided into an observation group(71 cases)and a control group(1 cases)according to the random number table method.The patients in the control group were trea-ted with mesalazine,and those of the observation group were combined with Gancao Xiexin Decoction on the basis of the control group.The treatment course of the two groups was 12 weeks.The clinical efficacy of the two groups after 12 weeks of treatment was compared.The severity of intestinal mucosal lesions[modified Mayo score and Geboes index]and intestinal barrier function[endotoxin,diamine oxidase(DAO)and D-lactic acid]before and after 12 weeks of treatment were compared.Tryptophan me-tabolism[kynurenine(Kyn),kynurenic acid(KynA)and quinolinic acid(QuinA)]and adverse drug reactions were compared.Results The total effective rate of the observation group(91.55%,65/71)was higher than that of the control group(74.65%,53/71)(P<0.05).After treatment of 12 weeks,the modified Mayo score and Geboes index of UC patients of the two groups were lower than those before treatment(P<0.05).The modified Mayo score and Geboes index of the observation group were lower than those of the control group(P<0.05).After treatment of 12 weeks,the levels of endotoxin,DAO and D-lactic acid of the two groups were lower than those before treatment(P<0.05).The levels of endotoxin,DAO and D-lactic acid of the observa-tion group were lower than those of the control group(P<0.05).After treatment of 12 weeks,the ratio of QuinA/Kyn of the two groups was lower than those before treatment,while the ratios of KynA/QuinA and KynA/Kyn were higher than those before treatment(P<0.05).The ratio of QuinA/Kyn of the observation group was lower than that of the control group,while the ratios of KynA/QuinA and KynA/Kyn were higher than those of the control group(P<0.05).After treatment of 12 weeks,the IBDQ scores of the UC patients in the two groups were significantly increased(P<0.05).The IBDQ scores of UC patients in the obser-vation group were higher than those of the control group(P<0.05).The two groups had no obvious adverse reactions during the treatment.Conclusion Modified Gancao Xiexin Decoction combined with mesalazine has a good effect on patients with UC,which can reduce the severity of intestinal mucosal lesions and improve the intestinal barrier function and tryptophan metabolism in pa-tients.

Modified Gancao Xiexin Decoction(甘草泻心汤加减)mesalazineulcerative colitisintestinal function barriertryptophan metabolism

王秋晓、唐学贵、唐诗宇、李倩

展开 >

川北医学院附属医院,四川南充 637000

甘草泻心汤加减 美沙拉嗪 溃疡性结肠炎 肠道功能屏障 色氨酸代谢

国家自然科学基金项目

81573990

2024

中华中医药学刊
中华中医药学会 ,辽宁中医药大学

中华中医药学刊

CSTPCD北大核心
影响因子:1.007
ISSN:1673-7717
年,卷(期):2024.42(7)